| Tigecycline |
% inhibited at MIC |
||||||
|---|---|---|---|---|---|---|---|
| Orqanism (#) | MIC50 | MIC90 | ≤0.25 | 0.5 | 1 | 2 | 4 |
| Acinetobacter spp. (921) | 0.25 | 1 | 50 | 66.8 | 91 | 98.4 | 99.9 |
| E. faecalis/faecium (1,034) | 0.06 | 0.12 | 99.6 | 100 | – | – | – |
| VREa (232) | 0.06 | 0.12 | 99.6 | 100 | – | – | – |
| EC, KO, KPb (3,506) | 0.25 | 1 | 64.5 | 86.9 | 94.7 | 97.6 | 99.7 |
| ESBLc (166) | 1 | 2 | 26.5 | 48.8 | 83.1 | 93.4 | 98.8 |
| H. influenzae (860) | 0.12 | 0.25 | 94.7 | 97.7 | 99.9 | 100 | – |
| P. aeruginosa (1,338) | 8 | >16 | 0.7 | 1.3 | 2.5 | 5 | 16.9 |
| S. aureus (MS) (826) | 0.12 | 0.12 | 99.6 | 100 | – | – | – |
| S. aureus (MR) (870) | 0.12 | 0.25 | 99.6 | 100 | – | – | – |
| S. pneumoniae (972) | 0.06 | 0.5 | 83 | 93.7 | 99.9 | 100 | – |
VRE, E. faecium/faecalis phenotypes
EC, E. coli; KO, K. oxytoca; KP, K. pneumoniae
ESBL, producing EC, KO and KPM